The DNA damage response depends on ubiquitin signalling to orchestrate DNA repair. The Fanconi Anemia pathway for interstrand crosslink repair, and the translesion synthesis pathway for DNA damage tolerance, both require cycles of monoubiquitination and deubiquitination. The ubiquitin specific protease USP1 regulates both these pathways by deubiquitinating monoubiquitinated PCNA, FANCD2 and FANCI. Loss of USP1 activity gives rise to chromosomal instability.
Introduction
Ubiquitination is a reversible post-translational modification that regulates almost every cellular process in eukaryotes. Cycles of ubiquitination and deubiquitination orchestrate the assembly and disassembly of many DNA repair complexes in DNA damage response pathways. These include the Fanconi Anemia (FA) pathway, required to repair DNA interstrand crosslinks (ICLs), and the translesion synthesis pathway (TLS), required for DNA damage tolerance 1 . FA is a chromosomal instability disorder that results from a dysfunctional ICL repair pathway 2 . Central to FA ICL repair is monoubiquitination of two homologous proteins, FANCD2 and FANCI, at two specific lysines, K561 and K523, respectively, catalysed by FANCL E3 and Ube2T E2 3 . Monoubiquitinated FANCD2 (FANCD2-Ub) signals multiple DNA repair proteins to conduct ICL repair 2 . A similar specific modification is central to TLS repair, where K164 of PCNA is monoubiquitinated (PCNA-Ub) by the RAD18 E3 ligase and Rad6 E2 4 . PCNA-Ub recruits TLS polymerases for DNA repair 5 . As well as ubiquitination, both ICL and TLS repair require deubiquitination (removal of ubiquitin). Interestingly, although the modifications in each pathway are assembled by distinct enzymes, they are removed by the same deubiquitinase, the USP1-UAF1 complex [6] [7] [8] . Loss of USP1 function results in an accumulation of monoubiquitinated FANCD2, FANCI and PCNA, genomic instability and a failure to complete the pathways 7, [9] [10] [11] [12] . In addition to these three substrates, USP1 deubiquitinates a number of other substrates including inhibitor of DNA binding proteins 1-4 (ID1-4) which regulate cell differentiation 13 and TBK1 which is involved in viral infection 14 .
USP1 belongs to the largest family of deubiquitinases (DUBs), the ubiquitin specific proteases (USPs), which contain ~50 members. Many USPs show little substrate discrimination between ubiquitin-ubiquitin chains in vitro 15 , and can hydrolyse polyubiquitin chains from substrates 16 . A few USPs exhibit preference for specific ubiquitin-ubiquitin linkages such as USP30 for K6-linked Ub chains 17 . In contrast, USP1 targets monoubiquitinated substrates, and regulates a distinct set of modified proteins. Although molecular mechanisms of ubiquitin removal from ubiquitin are well understood, it is less clear how ubiquitin-substrate linkages are specifically targeted.
The core catalytic USP domain is ~350 amino acids. However, most USPs also contain multiple insertions within the catalytic domain and additional N/C-terminal extensions 18 . USP1 has multiple insertions and an extended N-terminus on its USP domain, their functions are currently unknown.
USP1 has little DUB activity on its own, but is regulated by and forms a stoichiometric complex with UAF1. UAF1 also binds and activates two other DUBs, USP12 and USP46 19 , and studies that reveal how UAF1 binds and activates USP12 and USP46 suggest that UAF1 will bind to USP1 in an analogous manner 20, 21 . UAF1 acts to stabilise its USP partners and increase catalytic activity 22 , and UAF1 knockout in mice is embryonic lethal, while USP1 knockouts result in a FA-like phenotype, reflecting the additional functions of UAF1 9, 23 . In addition to its activation role, UAF1 has a C-terminal Sumo-like domain (SLD) responsible for recruiting USP1 indirectly to FANCD2 and PCNA via a weak interaction with FANCI and ATAD5, respectively 24 . Despite the common activator function of UAF1, loss of either USP12 or USP46 does not result in accumulation of USP1 substrates 19 , thus it remains unclear how USP1 specifically targets its substrate pool.
Investigating how USPs deubiquitinate their substrates on a molecular level is very challenging due to the difficulty in making physiological and correctly ubiquitinated substrates. To date most of our understanding of DUB specificity has used ubiquitin-ubiquitin linkages as substrates, likely due to the advances in purifying large quantities of ubiquitin chains. However, there are few examples of studies which have used monoubiquitinated substrates with a native isopeptide, and these include PCNA-Ub 25 and histones 26 . Particularly in the case of histone H2A and H2B, the generation of monoubiquitinated substrates has facilitated the elucidation of the mechanisms of substrate targeting by histone-specific DUBs 26, 27 . The ability to make physiological substrates allows for a modular approach to understanding the requirements for specificity and how DUBs such as USP1 work at the molecular level.
Here we report the reconstitution of substrate deubiquitination by USP1-UAF1 that allows for a modular approach to understanding the molecular requirements for deubiquitination of physiological substrates. We define the molecular determinants for substrate deubiquitination via a few residues in a highly conserved and extended N-terminus of USP1. Our analysis indicates that the N-terminus of USP1 harbours a FANCD2 specific binding sequence important for only deubiquitinating one specific lysine on FANCD2, K561the location of a specific DNA repair signal. Remarkably, we find that the N-terminus of USP1 is important for FANCD2-K561Ub deubiquitination but not for PCNA-K164Ub or FANCI-K523Ub. Finally, we find that the N-terminus of USP1 is sufficient to engineer specificity in a more promiscuous DUB. Our analysis show that USP1 discriminates between substrates and has direct elements for targeting FANCD2, regardless of whether it is ubiquitinated providing further insights into how USPs select their substrates.
Results

USP1 catalytic domain is sufficient for activity and binding to UAF1
To gain insight into USP1 specificity, we analysed the amino acid sequence and separated the protein into regions termed USP domain, Insert 1, Insert 2 and Nterminus ( Figure 1A) . Several elements important for cellular regulation have been previously identified; such as a calpain cleavage site within the N-terminus 28 , a degron motif for APC/C targeting within insertion 1 29 and an auto-cleavage region (G670/G671) within insertion 2 7 . However, whether these regions are important for in vitro DUB activity is unknown. We designed multiple USP1 fragments for expression in sf21 cells, keeping the catalytic domain intact, but systematically removing the insertions and N-terminus ( Figure 1B ). Each construct of USP1 is expressed and purified to homogeneity ( Figure 1C ). In order to assess catalytic activity and competency we used Ubiquitin-propargylamine (Ub-prg), a suicide probe which crosslinks to the active site cysteine residue of DUBs 30 . Recombinant USP1 FL in addition to all of the other fragments fully reacts with Ub-prg ( Figure 1C ), thus indicating the catalytic domain is competent and able to bind ubiquitin. USP1 FL has multiple break down products, but when insertion 1 and 2 are deleted, the yield and purity is much higher, indicating an increase of protein stability. Indeed, thermal denaturation assays reveal that USP1 ΔNΔ1Δ2 is more thermostable (Tm = 44 ± 0.24°C, whereas the USP1 FL melts at lower temperatures (Tm = 37 ± 0.81°C ( Figure   EV1 ). Importantly, USP1 requires to be in complex with UAF1 for robust catalytic activity 22 . We find that the minimal USP1 catalytic domain (USP1 ΔNΔ1Δ2 ) is sufficient for binding to UAF1 by size exclusion chromatography ( Figure 1D ) and stimulating activity of USP1 on a fluorescent ubiquitinated-dipeptide substrate, Ub-KG TAMRA ( Figure 1E ). The cleavage rates shows that the activity of USP1 ΔNΔ1Δ2 is almost identical to USP1 FL -UAF1. Since a minimal pseudo substrate was used, we further assayed the activity against K63 and K48 linked di-ubiquitin chains ( Figure 1F ) and do not detect any differences in activity between USP1 FL and USP1 ΔNΔ1Δ2 . Together, these data show that the catalytic domain of USP1, with stoichiometric amounts of UAF1, is sufficient for DUB activity, and that the additional regions of USP1 are not important for in vitro DUB catalysis or UAF1 stimulated activity.
USP1-UAF1 directly deubiquitinates monomeric FANCD2-Ub and FANCI-Ub
The USP1-UAF1 complex can deubiquitinate several monoubiquitinated substrates, including human FANCD2-Ub (hsFANCD2-Ub) 6 , human FANCI-Ub (hsFANCI-Ub) 31 and human (hsPCNA-Ub) 25 . In order to understand the requirements for deubiquitination we optimised a robust method for producing full length isolated hsFANCD2-Ub and hsFANCI-Ub substrates. The homogenous preparation of isolated hsFANCD2-Ub and hsFANCI-Ub is very challenging, as studies required non-mammalian FANCD2 and FANCI complexes, in addition to needing DNA, and a 6 protein complex (FANCC, FANCE, FANCF, FANCB, FANCL and FAAP100) to stimulate the modification 32 . To enhance the yield and purity of hsFANCD2-Ub and hsFANCI-Ub, we developed a method that requires a FANCL fragment (N-terminally truncated), a hyperactive mutant form of Ube2T V3 33 , E1 and ubiquitin. Using these enzymes ( Figure 2A ), we observe robust monoubiquitination of the isolated substrates hsFANCD2 and hsFANCI substrates within 60 min when monitored with either fluorescent ubiquitin (Ub 800 ) ( Figure EV2 ) or GST-Ub ( Figure 2B ). In order to ensure site-specificity of ubiquitination, we mutated K561 and K523 to Arg in hsFANCD2 and hsFANCI, respectively. In contrast to wild-type (WT) hsFANCD2 and hsFANCI, K561R and K523R is not monoubiquitinated using these reaction conditions, indicating site specificity is maintained ( Figure 2B ). We further assessed site-specificity by purifying hsFANCD2-Ub and hsFANCI-Ub to homogeneity and analysed both modified and un-modified proteins by mass spectrometry to verify is the correct lysine was ubiquitinated. We detect ubiquitin on FANCD2 K561 and FANCI K523 and do not detect any secondary ubiquitination events ( Figure EV3 ). In addition, these reaction conditions also support full monoubiquitination of the isolated Xenopus leavis (xl) FANCD2 and FANCI substrates ( Figure EV2 ). Purification profiles of both hsFANCD2-Ub and hsFANCI-Ub show no apparent changes in oligomeric state or hydrodynamic radius compared to non-ubiquitinated proteins ( Figure 2C ). Finally, we purified hsPCNA-Ub using a previously described method that uses a mutant E2 (UbcH5c S22R 25 ) ( Figure 2C ). With the substrates purified ( Figure 2C ), we assessed whether hsFANCD2-Ub, hsFANCI-Ub or hsPCNA-Ub are directly deubiquitinated by USP1 FL -UAF1 in vitro. The recombinant USP1 FL -UAF1 is able to fully deubiquitinate hsFANCD2-Ub, hsFANCI-Ub and hsPCNA-Ub at substoichiometric concentrations, in a UAF1 dependent manner ( Figure 2D ). In contrast, a catalytically-dead mutant of USP1 (C90S) is unable to deubiquitinate any of the substrates ( Figure 2D ). Taken together, these data establish that recombinant USP1-UAF1 is able to directly deubiquitinate diverse monoubiquitinated substrates in vitro without the need for auxiliary factors.
The N-terminus of USP1 is critical for FANCD2-Ub deubiquitination
To understand the minimum requirements for deubiquitination, we wondered whether the catalytic domain of USP1 is sufficient for deubiquitinating its physiological substrates. In order to test this, we assayed multiple USP1 fragments.
As shown, USP1 FL -UAF1 deubiquitinates hsFANCD2-Ub, hsFANCI-Ub and hsPCNA-Ub ( Figure 3A ). In addition, the catalytic module (USP1 ΔNΔ1Δ2 -UAF1) is sufficient at deubiquitinating hsFANCI-Ub ( Figure 3A) . Surprisingly, USP1 ΔNΔ1Δ2 -UAF1 is unable to deubiquitinate hsFANCD2-Ub and there is slower activity on hsPCNA-Ub at early time points ( Figure 3A ), indicating the catalytic domain is not sufficient despite the catalytic domain being active on other substrates including hsFANCI. In light of this unexpected result, we wanted to determine which deleted region of USP1 is responsible for the loss in deubiquitinating activity on hsFANCD2-Ub. We therefore assayed each deletion: USP1 ΔN , USP1 Δ1 and USP1 Δ2 . Both deletions of insert 1 and 2 cleave at the same rate as USP1 FL , however, deletion of the N-terminus results in a large loss of activity on hsFANCD2-Ub ( Figure 3B ). In contrast to hsFANCD2-Ub, none of the deletions have any effect on hsFANCI-Ub deubiquitination or hsPCNA-Ub deubiquitination ( Figure 3B ). Since the minimal USP1 ΔNΔ1Δ2 is still an active deubiquitinase we wanted to determine whether at higher concentrations hsFANCD2-Ub could be deubiquitinated by this fragment. Full deubiquitination of hsFANCD2-Ub can be achieved by increasing the concentration of USP1 ΔNΔ1Δ2 to a 1:1 ratio ( Figure 3C ). This is in contrast to USP1 Δ1Δ2 , which is able to deubiquitinate hsFANCD2-Ub at sub-stoichiometric concentrations ( Figure   3C ). These data indicate that although the N-terminus is not required for catalytic activity per se, the N-terminus contributes to a much more productive hsFANCD2-Ub deubiquitinase.
A recent report suggests that xlFANCI is required for human USP1-UAF1 to remove ubiquitin from xlFANCD2-Ub 32 . In contrast, we find that hsFANCD2 does not require the presence of hsFANCI in order to be deubiquitinated. Therefore, we wondered if our observation was due to the use of hsFANCD2 substrate. In order to test this, we purified xlFANCD2-Ub to homogeneity ( Figure EV2 ) and assayed with human USP1-UAF1. In contrast to previous reports, we find that USP1 FL and USP1 Δ1Δ2 are able to fully deubiquitinate xlFANCD2-Ub ( Figure 3D ). Furthermore, consistent with our observations using hsFANCD2-Ub as substrate, deletion of the N-terminus reduces USP1 activity for xlFANCD2-Ub ( Figure 3D ). Since deletion of the N-terminus of USP1 does not result in a defect for Ub-KG TAMRA ( Figure 1E ), K63/K48 diUb ( Figure   1F ), hsFANCI-Ub ( Figure 3B ) and hsPCNA-Ub ( Figure 3B ), it is likely that the Nterminus is a specific FANCD2-Ub requirement that is extended from the catalytic domain. Taken together these data suggest that the N-terminus of USP1 harbours a substrate targeting sequence specific for FANCD2.
The N-terminus drives specific FANCD2 K561-Ub deubiquitination
The ubiquitination site of FANCD2 is at a specific residue, K561. We wondered whether the FANCD2 targeting by the N-terminus of USP1 also extends to the site of ubiquitination i.e. K561-Ub. To test this we generated FANCD2 and modified lysines distinct from K561 ( Figure 4A ). We decided to use a mutant E2 (UbcH5c S22R ) which primarily monoubiquitinates proteins 25 . As monoubiquitination activity was weak, we used the E3 ligase RNF4 fragment (RNF4-RING fusion, RNF4 RR ) to increase the activity 34 . The UbcH5c S22R and RNF4 RR pair resulted in robust and multipleubiquitination events on hsFANCD2 ( Figure 4B ). To ensure K561 is not being monoubiquitinated by UbcH5c S22R and RNF4 RR , we used K561R hsFANCD2 as the substrate. We performed an E3 assay to monoubiquitinate hsFANCD2 and hsFANCD2 K561R, which we term hsFANCD2 K561-Ub and hsFANCD2 KX-Ub, respectively ( Figure 4A ), and treated the reaction with USP1 FL -UAF1 or USP1 ΔN -UAF1. Interestingly, while USP1 FL -UAF1 deubiquitinates both substrates K561-Ub and KX-Ub at similar rates, the USP1 ΔN -UAF1 shows clear activity on KX-Ub but little detectable activity on K561-Ub ( Figure 4C and 4D). These data show that the USP1 N-terminus targeting sequence also specifies the site for deubiquitination of FANCD2-Ub i.e. K561.
The N-terminus of USP1 contains critical residues for FANCD2-Ub deubiquitination
In order to identify residues within the N-terminus of USP1 required for hsFANCD2-Ub specificity, we looked at regions that are well conserved ( Figure 5A ). The Nterminus of USP1 is almost completely conserved from humans to zebrafish between residues 19-40 ( Figure 5A ). To screen mutants of USP1, we optimised and purified USP1 Δ1Δ2 and N-terminus variants from E.coli ( Figure EV4 ). Similar to deleting residues 1-54 of USP1, deletion of residues 21-29 also resulted in a specific loss in activity for hsFANCD2-Ub but not hsPCNA-Ub ( Figure 5B ). We next determined whether any of the side chains are important, so we mutated each residue to alanine and assayed for DUB activity using Ub-prg, hsPCNA-Ub, hsFANCI-Ub and hsFANCD2-Ub ( Figure EV4 and EV5). All point mutants are active with Ub-prg, hsPCNA-Ub and hsFANCI-Ub, in contrast, there is a loss in activity for several point mutants N21A, R22A, L23A, S24A and K26A on hsFANCD2-Ub deubiquitination ( Figure EV5 ). To quantify the relative differences between USP1 mutants we purified hsFANCD2-Ub with a fluorescently labelled Ub 800 that allows us to detect only the ubiquitinated FANCD2 (hsFANCD2-Ub 800 ) ( Figure EV6 ). Using this approach we monitored the deubiquitination of hsFANCD2-Ub 800 by each mutant and quantified the remaining FANCD2-Ub as a percentage of the input ( Figure 5C ).
We find that while USP1 Δ1Δ2 -UAF1 cleaves ~80% of the hsFANCD2-Ub 800 , USP1 ΔNΔ1Δ2 -UAF1 shows no apparent cleavage ( Figure 5C ). Interestingly, R22A and L23A were able to only deubiquitinate ~10% of the hsFANCD2-Ub 800 ( Figure 5C ). We did not further characterise L23A as it co-purifies with a large contaminant chaperone, which may suggest some misfolding ( Figure EV4 ). We next wondered whether the charge at R22 is critical for deubiquitination as it is conserved as a lysine in zebrafish ( Figure 5A ). We generated R22K, R22A and R22E variants. As expected, R22A, R22E and R22K have no effect on hsPCNA-Ub or hsFANCI-Ub deubiquitination ( Figure 5D ). In contrast, we observe that R22A has an intermediary affect and R22E is comparatively more compromised on hsFANCD2-Ub deubiquitination ( Figure 5D ). R22K retains WT activity on hFANCD2-Ub ( Figure 5D ), suggesting a positive charge is required. Finally, we showed in the full length USP1-UAF1 context, a single point mutation in its N-terminus (R22E) is sufficient for specifically disrupting hsFANCD2-Ub deubiquitination but not hsFANCI-Ub or hsPCNA-Ub ( Figure EV7 ). Taken together, these data indicate that R22 plays an important role in deubiquitination of hsFANCD2-Ub. However, it is clear that multiple conserved residues (N21, R22, L23, S24 and K26), that are within a short N-terminal region, drive USP1 mediated FANCD2-Ub deubiquitination.
The N-terminus of USP1 is a FANCD2 recognition element
Mutation or deletion of the USP1 N-terminus specifically and negatively impacts FANCD2-Ub deubiquitination. We hypothesised that this region in the N-terminus of USP1 encodes a FANCD2 binding site. To test this, we purified UAF1 with an Nterminal Strep tag and formed stable complexes with USP1 Δ1Δ2 or USP1 ΔNΔ1Δ2 harbouring C90S mutations in order to disrupt catalytic activity. We assayed interaction with hsFANCD2-Ub and find that USP1 Δ1Δ2 -UAF1 complexes can capture hsFANCD2-Ub ( Figure 6A ). In contrast, assaying capture with USP1 ΔNΔ1Δ2 -UAF1, we detect little hsFANCD2-Ub capture on beads, when compared to USP1 Δ1Δ2 ( Figure   6A ). Since the interaction is defective but not absent with USP1 ΔNΔ1Δ2 when using hsFANCD2-Ub, we wondered whether the ubiquitin on hsFANCD2 is required for the N-terminus to interact. We find that unmodified hsFANCD2 interacts with USP1 Δ1Δ2 ( Figure 6A ). In contrast, we do not detect capture of hsFANCD2 when using USP1 ΔNΔ1Δ2 as bait ( Figure 6A ). These data show that USP1 interacts with hsFANCD2 regardless of ubiquitination, but shows that the interaction is fully dependent on the N-terminus. Since we detect an interaction with USP1 ΔNΔ1Δ2 with hsFANCD2-Ub, albeit much less than with the N-terminus, this suggests a ubiquitinmediated interaction, likely through the catalytic domain of the USP1 ( Figure 6A ).
As USP1's interaction with hsFANCD2 is dependent on the N-terminus, we wanted to determine whether this is specific for hsFANCD2, so we similarly assayed interactions of hsFANCI and hsPCNA. Interestingly, we can detect an interaction with hsFANCI and hsFANCI-Ub, but that is unaffected by deletion of the N-terminus of USP1 ( Figure EV8 ). We could not detect an interaction between USP1 and hsPCNA, but we observe interaction with hsPCNA-Ub ( Figure EV8 ). Which again likewise and consistent with deubiquitination assays, is not dependent on the Nterminus of USP1. Together this data indicates that the N-terminus of USP1 specifically interacts with hsFANCD2 regardless of ubiquitination. We do note an enhancement in interaction with hsFANCD2-Ub when compared to hsFANCD2 and thus suggest that there are two points of interaction; FANCD2: N-term and USP domain: ubiquitin.
A chimera fusion of USP1 N-terminus to USP2 catalytic domain provides FANCD2 specificity
Deletion of the N-terminus of USP1 does not appear to affect the catalytic activity of the catalytic module (USP1 ΔNΔ1Δ2 ), except in the case of hsFANCD2-Ub deubiquitination. We therefore wondered whether the N-terminus can increase the efficiency of FANCD2-Ub deubiquitination of a distinct DUB module. To test this, we chose the catalytic domain of USP2, generally considered promiscuous deubiquitinase due to its lack of substrate specificity 35 . We created and purified a chimeric fusion USP1 1-60 -USP2 where residues 1-60 of USP1 are N-terminal to the USP2 catalytic domain ( Figure 6B ). We find that USP2 at 100 nM is able to completely deubiquitinate 1µM hsFANCD2-Ub by 40 min ( Figure 6B ), in contrast, the chimeric USP1 1-60 -USP2 achieves this in 10 min ( Figure 6B ). Since the N-terminus increases USP2 activity against hsFANCD2-Ub, we asked whether the N-terminus increases activity of USP2 towards other ubiquitinated substrates. In contrast to hsFANCD2-Ub, there are no differences in activity of USP2 and the USP1 1-60 -USP2 chimera on either hsFANCI-Ub ( Figure 6C ) or hsPCNA-Ub ( Figure 6D ). These data
show that the addition of the N-terminus in cis confers a gain-of-activity to USP2.
The N-terminus of USP1 contains a FANCD2 determinant sequence that functions at the core of FANCD2 deubiquitination by specifically binding and increasing deubiquitination efficiency ( Figure 6E ).
Discussion
A cycle of monoubiquitination and deubiquitination of FANCD2 is critical for completion of FA ICL repair 8 . Removal of the ubiquitin signal from FANCD2 is conducted by the USP1-UAF1 deubiquitinase, and disruption of USP1 catalytic activity results in an accumulation of FANCD2-Ub and FA-like phenotypes 6, 9, 11, 23 .
Despite multiple DUBs existing at DNA replication and repair foci, USP1 appears to be the only DUB whose loss results in an accumulation of FANCD2-Ub 6 . The molecular determinants and mechanisms of how DUBs such as USP1 target and regulate distinct pools of substrates have remained elusive, due to the lack of molecular insights into the process. Here we report a unique feature at the Nterminus of USP1 and a potential short linear interacting motif (SLIM) at the N-terminus explains that it specifically and directly targets K561 of FANCD2, providing a molecular foundation for how USP1 targets one of its substrates with high specificity.
USP1 activity is subject to layers of regulation during cell-cycle progression. For example, USP1 is turned over throughout the cell cycle, activated and stabilised by binding partners such as UAF1 and, in addition, undergoes autocleavage to allow targeting by both the N-end rule and C-end rule pathways 7, 11, 22, 36 . However, we show that USP1, in complex with UAF1, deubiquitinates at least three DNA repair related substrates in vitro; FANCD2-Ub, FANCI-Ub and PCNA-Ub. Thus, this suggests everything essential for deubiquitination is encoded within USP1-UAF1. Interestingly, UAF1 is an abundant protein with multiple functions including activating USP12 and USP46 19 . It has been suggested that UAF1 may indirectly target USP1 to specific substrates such as FANCD2 or PCNA via a C-terminal sumo-like domain (SLD) that binds to sumo-like interacting motifs on protein partners of FANCD2 and PCNA 24 ( Figure 6E ). However, disruption of either USP12 or USP46 does not affect FANCD2-Ub levels, showing that FANCD2 is not an overlapping substrate 19 . Since the SLD would target multiple DUBs to the same substrates, further layers of regulation may exist to ensure the correct DUB is targeted to FANCD2-Ub or PCNA-Ub. By reconstituting FANCD2-Ub deubiquitination by USP1-UAF1, we identified the minimal components required for deubiquitination and discover a unique sequence within the N-terminus of USP1 critical for removing ubiquitin from FANCD2 ( Figure   6E ). The N-terminus bound specifically to FANCD2, even in the absence of ubiquitin, and did not bind to PCNA or FANCI. Thus USP1 displays a higher level of substrate targeting for FANCD2. It is interesting that the N-terminus of USP1 is not required for FANCI-Ub deubiquitination, since FANCI shares a similar ubiquitination site to FANCD2 both structurally and on a sequence level, allowing us to speculate that perhaps FANCD2 is the major substrate of USP1. USP1 targets multiple substrates, so it will be exciting to determine what further features USP1 or even the substrates have that may contribute to substrate targeting and catalysis, either through the Nterminus or insertions of USP1 or even unique features of the substrates.
It is interesting that activity of USP1 is lost for FANCD2-Ub deubiquitination when deleting the N-terminus but not for the other substrates. This specific loss in activity suggests that USP1 without the N-terminus may struggle to form a productive enzyme-substrate complex with FANCD2. The N-terminus of USP1 is an extension of the USP domain and is ~75 amino acids in length. It is unclear how flexible, structured or compact the N-terminus may be in relative position to the USP domain and catalytic site. Therefore, it is difficult to predict whether the N-terminus of USP1 directly contributes to catalysis when FANCD2 is bound, or simply acts to recruit FANCD2-Ub and stabilise the isopeptide bond within the active site. Since USP1 ΔN -UAF1 loses activity for ubiquitinated K561, but not for other lysines of FANCD2, this allows us to speculate that the N-terminus binds and precisely positions FANCD2 in order to increase activity for a specific lysine position. It can also be suggested that FANCD2-K561-Ub is not in a fully accessible conformation for deubiquitination, and that the N-terminus modulates this conformation to allow formation of a more productive complex. This is reminiscent of a recently identified monoubiquitination site of SETDB1, which protects the ubiquitin from deubiquitination via multiple SETDB1-Ubiquitin interactions 37 , perhaps FANCD2 also partially protects and occludes ubiquitin at K561, and the N-terminus is required to relieve this effect. It will be interesting to determine how the N-terminus binds to FANCD2, how it modulates USP1 function towards FANCD2 and whether other PTMs or processes within the Nterminus can modulate its function.
It is not understood how the majority of USPs maintain specificity as most of them target a common factor, ubiquitin. Interestingly, USPs have distinct sets of substrates as individual knockdown of DUBs will only affect certain substrates 6 . For some USPs they target a specific signal, for example, USP18 has a unique hydrophobic patch within the USP domain which targets a unique hydrophobic patch to the ubiquitin-like protein ISGN15 38 . Other examples include USP30, which shows preference for K6 linked ubiquitin chains via several residues in the USP domain 17, 39 . However, here we have an example, USP1, which we have shown targets a specific ubiquitinated substrate, and therefore recognise both ubiquitin and the substrate itself. A similar example to this could be monoubiquitinated lysines on histones, which are commonly targeted for DNA repair signalling events. For example, Histone 2B is monoubiquitinated on K120 and targeted by the SAGA DUB module, a four protein complex which contains USP22 (Ubp8 homolog in yeast). Interestingly, while Ubp8 showed contributions for targeting nucleosomes via several residues, other members of the complex such as sgf11 made more significant contributions via the acidic patch on H2A/H2B, and therefore likely governs most of the substrate specificity 27 .
While SAGA-DUB achieves specificity via a protein complex, other DUBs such as USP7 contain substrate targeting regions within the same polypeptide. USP7 displays substrate targeting regions via its N-terminal TRAF domain for p53 40 .
However, in contrast to the effect we see with disruption of USP1's N-terminus on FANCD2-Ub deubiquitination, the N-terminus of USP7 only had a minor effect on p53 deubiquitination in vitro, indicating it is not critical for forming a productive enzyme-substrate complex 41 . We show that USP1 specifically targets one ubiquitinated lysine made by a specific E3 ligase, FANCL. Another DUB, USP48, was recently published to also specifically oppose the monoubiquitination made by another lysine specific E3 ligase BRCA1 26 . This suggests that some DUBs and E3 activities may have co-evolved to oppose each other on specific cellular signals and maintain an appropriate equilibrium of non-ubiquitinated and ubiquitinated substrate.
Arguably the most important known function of USP1 is to regulate FANCD2, as the monoubiquitinated form is important for both ICL repair and also origin of replication firing in latent conditions 42 . In addition, non-ubiquitinated FANCD2 is important in DNA surveillance mechanisms 43 , meaning the presence of both FANCD2-Ub and FANCD2 is important for DNA integrity and cell proliferation. Moreover, USP1 depletion increases oncogene-induced senescence (OIS) and plays a pivotal role in protecting genomic instability by preventing FANCD2-Ub aberrant aggregation 12 .
USP1-UAF1 therefore works to recycle and maintain appropriate levels of both monoubiquitinated and un-ubiqutinated FANCD2. Inhibition of USP1-UAF1 activity by the specific small molecule, ML323, leads to an increased sensitivity to platinum based compounds in resistant cells 11 . Furthermore, the USP1-UAF1 complex has been shown to play critical roles in homologous recombination 10 . This collection of studies reveals that USP1 would be an excellent anti-cancer target by disrupting its ability to deubiquitinate FANCD2-Ub, as this would lead to OIS and cellular sensitivity to crosslinking agents 8, 9 . However, USP1-UAF1 targets multiple substrates including ID2 proteins and TBK1, meaning an all-around catalytic activity inhibitor may affect multiple processes, perhaps a more specific inhibitor that could block FANCD2-USP1 interaction, such as the N-terminus, would provide a more specific therapy.
Materials and Methods
Cloning
Full length USP1 FL with G670A/G671A (mutated autocleavage site 7 amplified with BamH1 at either end for ligation into a pGex6bp1 vector containing rat USP2 catalytic domain (GST-3C-USP1 1-60 -rUSP2 (271-618)). A mutant Ube2T with E54R, P93G, P94G, 1-152 (Ube2T V3 ) 33 . FANCL ΔELF (109-375) was cloned into a pET-SUMO (Invitrogen) vector using restriction free cloning. Tagless Ubiquitin, His-TEV Ubiquitin and His-TEV-PCNA are previously described 22, 44 . RNF4 (RING-RING domain fusion 34 ) was a kind gift from Ron Hay (University of Dundee). To introduce point mutations or truncations, PCR mutagenesis was performed using KOD Hot Start DNA Polymerase following manufacturer's instructions.
Protein expression and purification
Baculovirus were generated using the EMBacY MultiBac system (Geneva biotech) and USP1, UAF1, FANCD2 and FANCI proteins were expressed for ~72h in baculovirus infected sf21 cells. FANCL ΔELF , PCNA, ubiquitin constructs, Ube2T V3 and RNF4 RING-RING were expressed and purified in BL21 E.coli as previously described 34, 44 . USP1 Δ1Δ2 and USP2 were expressed using BL21 E.coli, grown to OD600: 0.6 and induced with 0.1 µM Isopropyl-Beta-d-Thiogalactopyranoside (IPTG) for 18h at 16°C. Fluorescently labelled ubiquitin was made as described previously 42 .
All steps of purifications were performed at 4°C and completed within 24-36 hours of lysis. Cell pellets were routinely suspended in lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5% glycerol, 10 mM imidazole, 10 mM 2-Mercaptoethanol with freshly added MgCl2 (2 mM), protease inhibitor (EDTA-free) tablets and benzonase. For FANCD2, FANCI and FANCL ΔELF and lysis buffer contained 400 mM NaCl. Sf21 cells were lysed by homogeniser followed by sonication at 40% amplitude, 10s on 10s off for 12 cycles. Suspended E.coli cells were sonicated at 80% amp, 20s on 40s off, 12 cycles. All lysates were clarified at 40,000 x g for 45 min and filtered (0.45 µM).
Proteins were bound to respective resins (either Ni-NTA for His tags or GSH for GST tags) and washed extensively with lysis buffer with 500 mM NaCl. GST tagged proteins were eluted by incubation with GST-precision protease or lysis buffer with 10 mM GSH. His-Smt3 tagged proteins were eluted by on column cleavage using His-ULP1 protease. His-TEV or His -3C tagged proteins were eluted by lysis buffer with 250 mM imidazole and lower NaCl for ion exchange chromatography (typically 100 mM NaCl). To remove tags, proteins were incubated with respective proteases (His-TEV protease or GST-precision protease) overnight and tagged proteases were removed by binding to respective resin. Tags were not removed from FANCD2, FANCI, USP2 or GST-Ubiquitin. Anion exchange for USP1, UAF1, FANCD2, FANCI, GST-USP2, GST-Ub and PCNA were all performed using a HPQ (1 ml or 5 ml) column and eluted with a linear gradient (50 mM Tris pH 8.0, 100-1000 mM NaCl, 5% glycerol and 10 mM 2-Mercaptoethanol). E.coli expressed USP1 was not purified by anion exchange.
Proteins were further purified using size exclusion chromatography (SEC). FANCD2 and FANCI were fractionated using an S6 Increase (10/300) column in 20 mM Tris pH 8.0, 400 mM NaCl, 5% glycerol, 5 mM DTT. USP1, UAF1 and E3s were fractionated using an SD200 Increase (10/300) in 20 mM Tris pH 8.0, 150 mM NaCl, 5% glycerol with 5 mM DTT. All ubiquitin constructs and E2s were fractionated using an SD75 (10/300) in 20 mM Tris pH 8.0, 150 mM NaCl, 5% glycerol, 0.5 mM Tris 2carboxyethyl-phosphine (TCEP). Proteins were concentrated to ~5 mg/ml for FANCD2/FANCI, ~4 mg/ml for FANCL ΔELF and ~10 mg/ml for all other proteins before flash freezing in liquid nitrogen and storage at -80°C.
Analytical Gel filtration of USP1-UAF1 complexes
Recombinant USP1 and UAF1 alone or together were incubated at 15 µM for 15 min on ice before fractionation on SD200 Increase (10/300) in 20 mM Tris pH 8.0, 150 mM NaCl, 5% glycerol and 5 mM DTT. Samples (10 µl) were mixed with SDS-page loading buffer (10 µl) and analysed via SDS-page (9%) and instant blue coomassie staining (Expedeon). All USP1 constructs co-eluted with UAF1.
Ubiquitin-propargylamine (Ub-prg)
Ub-intein-CBD in BL21 E.coli was grown to OD600: 0.6, induced with 0.5 µM IPTG and expressed for 24 h at 16°C. Cells were harvested and suspended in 50 mM 
Reacting Ub-prg with DUBs
To crosslink DUBs with Ub-prg, DUBs (2 µM) in 20 µl were incubated in DUB buffer (50 mM Tris pH 7.5, 120 mM NaCl, 10 mM DTT) with and without Ub-prg (6 µM) for 10 min at room temperature. Reactions were stopped by addition SDS-page loading buffer (Invitrogen) and visualised using 4-12% Bis-Tris SDS-PAGE gel (Invitrogen) run with NuPAGE™ MOPS SDS Running Buffer (Thermo Scientific) and coomassie staining a slower migrating band indicates reaction with Ub-prg.
Thermofluor assays
Thermofluor experiments were carried out using a CFX96 real-time PCR detection system (Bio-Rad). USP1 (40 µl) at 0.05-0.2 mg/ml in 50 mM Tris pH8.0, 120 mM NaCl, 10 mM DTT and 5x SYPRO orange was prepared in 96-well plates. The samples were heated from 25°C to 95°C with increments of 1°C/minute, and fluorescence was measured at each interval. Data was analysed as previously described 45 and a mean Tm°C was calculated from three different USP1 concentrations which were performed in triplicate.
Fluorescent polarisation (FP) assays with Ubiquitin-TAMRA assays
USP1-UAF1 were assembled by diluting USP1 variants (10 µM) and UAF1 (10 µM) in DUB buffer for 10 min at room temperature. For FP assays, USP1-UAF1 were diluted and incubated in DUB buffer with 0.1 mg/ml ovalbumin at 2X concentration 
Purifying monoubiquitinated proteins
Purification of PCNA monoubiquitinated at K164 (PCNA-Ub) was performed as previously described 25 . Monoubiquitinated FANCD2 at K561 and FANCI at K523 was purified using GST-Ub which leaves a 'GPLGS' over hang at the N-terminus of ubiquitin following precision protease cleavage. Typically, purified FANCD2 or 
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